Estrogen receptor modulators

Details for Australian Patent Application No. 2005302143 (hide)

Owner Merck & Co., Inc.

Inventors Fried, Amy; Wilkening, Robert R.

Agent Spruson & Ferguson

Pub. Number AU-A-2005302143

PCT Pub. Number WO2006/050402

Priority 60/623,910 01.11.04 US

Filing date 28 October 2005

Wipo publication date 11 May 2006

International Classifications

C07C 49/747 (2006.01) Ketones

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/275 (2006.01) - Nitriles

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

C07C 251/44 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07C 255/47 (2006.01) Carboxylic acid nitriles

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050402 Priority application(s): WO2006/050402

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302145-Methods and apparatus for parallel execution of a process

2005302106-Method, optical recording apparatus using such method and optical recording medium for use by the method and the apparatus